All Stories

  1. Climate change and psychiatric disability
  2. Self-harming behaviors among forensic psychiatric patients living with intellectual disability
  3. Problematic Use of Buspirone and Tandospirone: A Scoping Review
  4. Suicide decriminalisation in the United Arab Emirates
  5. Embracing virtual reality in medical education
  6. Self-harming behaviors among forensic psychiatric patients who committed violent offences: an exploratory study on the role of circumstances during the index offence and victim characteristics
  7. Racial and Ethnic Considerations for the Clinical Practice of Psychopharmacology and Research Methodology: A Narrative Review of the Growing Body of Literature
  8. Climate change and health issues: an Afrocentric perspective
  9. Impacts of extreme temperatures on mood disorders: A systematic review
  10. Dual harm among patients in the Ontario forensic mental health system
  11. Weapon use during the index offense: a study among forensic psychiatry patients in Ontario, Canada
  12. Mentorship in medical education: reflections on the importance of both unofficial and official mentorship programs
  13. Cancer and premature mortality—pushing the frontiers of cancer care
  14. Editorial: International Day of Happiness 2022: public mental health
  15. Introduction
  16. Animal-Assisted Intervention
  17. Electroretinography and suicidal behaviors: a systematic review
  18. Self-harming behaviors and forensic system-related factors: an analysis of the Ontario review board database
  19. Labia minora elongation: a neglected form of genital mutilation with mental and sexual health concerns
  20. Peer support mental health teams in correctional settings in Uganda
  21. From mentee to mentor: reflections on a pre-medical student mentorship program for underrepresented groups in medicine
  22. Solid Fuel Use and Health in Developing Countries
  23. An Educational Activity on Trauma Informed Care for Healthcare Learners
  24. The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
  25. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  26. Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  27. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
  28. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  29. Substance Use Disorders and Antisocial Personality Disorder among a Sample of Incarcerated Individuals with Inadequate Health Care: Implications for Correctional Mental-Behavioural Health and Addiction Services
  30. Demographic and clinical characteristics of lithium‐treated older adults with bipolar disorder
  31. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
  32. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  33. A Scoping Review on Barriers to Mental Healthcare in Canada as Identified by Healthcare Providers
  34. Insights About Cannabis and Psychosis Using Video Games for Young People With a First Episode of Psychosis, Particularly Those From Black Racialized Communities: Protocol for a Mixed Methods Study
  35. Anti-stigma training and positive changes in mental illness stigma outcomes in medical students in ten countries: a mediation analysis on pathways via empathy development and anxiety reduction
  36. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  37. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  38. Metabolism and risk
  39. Insights About Cannabis and Psychosis Using Video Games for Young People With a First Episode of Psychosis, Particularly Those From Black Racialized Communities: Protocol for a Mixed Methods Study (Preprint)
  40. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  41. Cognition in older adults with bipolar disorder: An ISBD task force systematic review and meta‐analysis based on a comprehensive neuropsychological assessment
  42. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  43. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review
  44. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  45. Combining Asian and American pedagogy to improve clinical psychopharmacology practice
  46. P.0415 Meta-analysis of cognitive performance in older adults with bipolar disorders
  47. A Student-Driven Advocacy Project to Address the Opioid Crisis in Canada: Implications for Developing Competency in Health Advocacy During Medical Training
  48. Global, regional, and national sex-specific burden and control of the HIV epidemic
  49. Mapping Anemia in Women: Global Trends and Inequality
  50. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  51. Healthcare professionals need to be CCLEAR: Climate collaborators, leaders, educators, advocates, and researchers
  52. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  53. Tracking development assistance for health and for COVID-19
  54. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status
  55. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  56. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
  57. Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study
  58. Measuring routine childhood vaccination coverage in 204 countries and territories
  59. Promoting climate change issues in medical education: Lessons from a student-driven advocacy project in a Canadian Medical school
  60. Psychological distress and sleep problems in healthcare workers in a developing context during COVID-19 pandemic: Implications for workplace wellbeing
  61. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning
  62. A comparative study of perceived burden in parent caregivers of adolescents with epilepsy in a resource-restricted setting: Investigating the explanatory factors of perceived burden
  63. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  64. Public health utility of cause of death data: applying empirical algorithms to improve data quality
  65. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
  66. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  67. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  68. Hearing loss prevalence and years lived with disability
  69. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
  70. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
  71. Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems
  72. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
  73. The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019
  74. Psychiatric Morbidity among Incarcerated Individuals in an Underserved Region of Nigeria: Revisiting the Unmet Mental Health Needs in Correction Services
  75. Mapping routine measles vaccination in low- and middle-income countries
  76. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  77. Adolescent Substance Misuse/Use Disorders: Characteristic Features
  78. Sexual Offender Recidivism
  79. Absconsion in forensic psychiatric services: a systematic review of literature
  80. Five insights from the Global Burden of Disease Study 2019
  81. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
  82. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  83. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  84. Self-stigma and decision about medication use among a sample of Nigerian outpatients with schizophrenia.
  85. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17
  86. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis
  87. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study
  88. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
  89. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  90. Psychosocial Wellbeing of Nigerian Teachers in Special Education Schools
  91. Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  92. Emotional distress among parent caregivers of adolescents with sickle cell disease: Association with patients and caregivers variables
  93. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  94. Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017
  95. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  96. Department of Error
  97. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017
  98. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  99. Implementation of risk assessment tools in psychiatric services
  100. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3
  101. Global trends of hand and wrist trauma: a systematic analysis of fracture and digit amputation using the Global Burden of Disease 2017 Study
  102. The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study
  103. GBD 2016. Occupational Carcinogens Collaborators
  104. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  105. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  106. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  107. Canadian Burden of Skin Disease From 1990 to 2017: Results From the Global Burden of Disease 2017 Study
  108. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017
  109. Significant Burden and Psychological Distress Among Caregivers of Children With Nephrotic Syndrome: A Cross-Sectional Study
  110. Mapping child growth failure across low- and middle-income countries
  111. Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
  112. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
  113. Mapping disparities in education across low- and middle-income countries
  114. Epidemiology of injuries from fire, heat and hot substances: global, regional and national morbidity and mortality estimates from the Global Burden of Disease 2017 study
  115. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  116. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  117. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017
  118. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
  119. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
  120. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
  121. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
  122. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
  123. Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017
  124. Department of Error
  125. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  126. Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome
  127. A longitudinal cohort study of symptoms and other concerns among Nigerian people with stages 3–5 chronic kidney diseases: study protocol
  128. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  129. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016
  130. Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  131. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  132. Responding to experienced and anticipated discrimination (READ): anti -stigma training for medical students towards patients with mental illness – study protocol for an international multisite non-randomised controlled study
  133. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  134. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  135. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017
  136. Predictors of caregiver burden after stroke in Nigeria: Effect on psychosocial well-being
  137. Evidence-Based Practice in the Evaluation and Treatment of Sexual Offenders
  138. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
  139. Cognitive and Functional Assessment of Psychosis Stratification Study (CoFAPSS): Rationale, Design, and Characteristics
  140. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study
  141. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  142. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  143. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  144. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...
  145. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  146. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  147. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  148. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  149. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  150. Department of Error
  151. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016
  152. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
  153. Global Mortality From Firearms, 1990-2016
  154. Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis
  155. Alcohol use and attributable disease burden in 195
  156. Does ceasing exercise induce depressive symptoms? A systematic review of experimental trials including immunological and neurogenic markers
  157. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  158. Mental health services in Nigerian prisons: Lessons from a four-year review and the literature
  159. Internalized stigma in schizophrenia: a cross-sectional study of prevalence and predictors
  160. Post-stroke depression: Prevalence, associated factors and impact on quality of life among outpatients in a Nigerian hospital
  161. The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015
  162. Evaluation of the roles of HIV co-infection and socio-demographic factors as determinants of Quality of Life among Nigerians with Tuberculosis
  163. Stress and training satisfaction among resident doctors in Nigeria: Any justification for a change in training policy?
  164. Department of Error
  165. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  166. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  167. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  168. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  169. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  170. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  171. Department of Error
  172. Disordered eating attitudes: demographic and clinico-anthropometric correlates among a sample of Nigerian students
  173. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  174. 322. Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex: A Review of Methods and Utility in Psychiatry
  175. Medication adherence among Nigerians with schizophrenia: correlation between clinico-demographic factors and quality of life
  176. Medication adherence among Nigerians with schizophrenia: correlation between clinico-demographic factors and quality of life
  177. Relationship between anxiety disorders and domains of health related quality of life among Nigerians with breast cancer
  178. Autism spectrum disorder in a community-based sample with neurodevelopmental problems in Lagos, Nigeria
  179. Children with neurodevelopmental disorders: The burden and psychological effects on caregivers in Lagos, Nigeria
  180. Poststroke anxiety disorders in a Nigerian hospital: Prevalence, associated factors, and impacts on quality of life
  181. Disability among attendees with schizophrenia in a Nigerian hospital: further evidence for integrated rehabilitative treatment designs
  182. Disability among attendees with schizophrenia in a Nigerian hospital: further evidence for integrated rehabilitative treatment designs
  183. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  184. Child’s symptom burden and depressive symptoms among caregivers of children with cancers: an argument for early integration of pediatric palliative care
  185. Anxiety disorders in breast cancer: Prevalence, types, and determinants
  186. Psychological distress and emotional pain among adult attendees of a dental clinic: a case-control study
  187. Psychological distress and emotional pain among adult attendees of a dental clinic: a case-control study
  188. Pattern of anxiety psychopathology experienced among postgraduate medical trainees
  189. Late-life depression: Burden, severity and relationship with social support dimensions in a West African community
  190. Impact of emotional distress on caregivers burden among Nigerian children with Obstructive Adenotonsillar hypertrophy
  191. Assessment of Functioning among Nigerians with Schizophrenia in a Tertiary Health Facility: Influence of Psychopathology, Socio-demographic and Treatment Factors
  192. Interplay of Anxiety and Depression With Quality of Life in Endstage Renal Disease
  193. A cross-sectional evaluation of the correlation between disease severity and quality of life in chronic rhinosinusitis patients in Nigeria
  194. Abstract 3845: Symptoms burden in subjects with cervical cancer and supportive care:A view from a developing country
  195. Burnout among doctors in residency training in a tertiary hospital
  196. Suicidal Ideation among Attendees of a West African HIV Clinic
  197. Symptoms burden in subjects with cervical cancer and supportive care: Preliminary result from a developing country
  198. Autism in Nigeria: A call for action
  199. Correlates of depressive illness among the elderly in a mixed urban community in Lagos, Nigeria
  200. Toward the integration of comprehensive mental health services in HIV care: An assessment of psychiatric morbidity among HIV-positive individuals in sub-Saharan Africa
  201. Toward integration of palliative care into cancer care: A study on profile of psychosocial and clinical complications among attendees of a Nigerian oncological center.
  202. A comparative analysis of disability in individuals with bipolar affective disorder and schizophrenia in a sub-Saharan African mental health hospital: towards evidence-guided rehabilitation intervention
  203. 593 – Sociodemographic profile, presentations and therapeutic interventions in a community psychiatry service in south-west, nigeria
  204. A multi-dimensional assessment of quality of life among attendees of a West African HIV clinic and its use in tracking outcome
  205. Screening for depression with Centre for Epidemiological Studies Depression Scale Revised and its implication for consultation-liaison psychiatry practice among cancer subjects: a perspective from a developing country
  206. A Study on Epidemiological Profile of Anxiety Disorders Among People Living with HIV/AIDS in a Sub-Saharan Africa HIV Clinic
  207. Factors associated with anxiety disorders among HIV-positive attendees of an HIV clinic in Lagos, Nigeria
  208. HIV/AIDS and psychological distress: The experience of outpatients in a West African HIV clinic
  209. A Controlled Study of Depression among Attendees of an Oncology Clinic in West Africa
  210. Predictive and risk factors of depression in a Western African Oncology Clinic
  211. Incidence and correlates of delirium in a West African mental health clinic
  212. Erratum to “Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria” [General Hospital Psychiatry 31 (2009) 167–174]
  213. P01-270 - Quality of life and sociodemographic factors of patients with unexplained symptom in general practice
  214. P02-35 - Incidence and correlates of delirium in a west African mental health clinic
  215. P03-208 - Correlates and prevalence of substance use among primary care patient in Ikorodu, Nigeria
  216. Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria